Skip to content

CHYM Chime Financial Inc

NASDAQ
Financials
Financial Services

$29.40

▼ 1.9%

Updated Oct 16, 2:25 PM ET

Report Card

CHYM at a glance — five pillars scored 0–100 from real filed financials.

How the 0–100 rating is calculated
Value
—
Growth
—
Profitability
0
Health
100
Dividends
—

Overall: not rated yet. This stock's fundamentals ratios aren't loaded, so only the pillars its filings support are scored.

Key Metrics

Market Cap

—

P/E

—

Forward P/E (est.)

—

ROE

—

Revenue Growth

—

EPS Growth

—

Profit Margin

—

FCF Yield

—

Debt / Equity

—

ROIC

-58.0%

Interest Coverage

—

Current Ratio

4.62x

Dividend Yield

—

Implied Growth (rev. DCF)

—

Rating Score

Not rated

Business Overview

Research

Chime Financial Inc (CHYM) is a NASDAQ-listed company in the Financial Services industry, within the Financials sector.

In its latest reported year it generated about $2.19B in revenue and posted a net loss of $1.01B.

Our model hasn't rated CHYM yet because its fundamentals ratios (P/E, margins, returns on capital, leverage) aren't loaded. Any financial history below comes straight from its SEC filings and refreshes automatically.

Revenue Growth

Research
How to read an income statement

2Y CAGR

30.8%

Revenue moved from $1.28B in 2023 to $2.19B in 2025, a 30.8% compound annual growth rate. The most recent year was roughly steady year over year. Slower, mature growth is common for established businesses.

0/1 checks passedROIC above 10%

Gross Margin

88.0%

Operating Margin

-47.6%

Net Margin

-46.2%

ROE

—

Debt Analysis

Research
1/1 checks passedShort-term bills covered

Total Debt

—

Net Debt

—

Net Debt / EBITDA

—

Debt / Equity

—

Leverage: debt-to-equity is n/a, with a current ratio of 4.6x. Detailed balance-sheet leverage is limited for this name.

Cash Flow Analysis

Research

Operating CF

$52.78M

Free Cash Flow

$32.89M

FCF Margin

1.5%

In the latest year Chime Financial Inc produced about $52.78M of operating cash flow and $32.89M of free cash flow after capital spending. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.

Valuation Analysis

Research
What is a reasonable P/E ratio?

P/E

—

P/S

—

P/B

—

EV / EBITDA

—

CHYM trades at n/a trailing earnings. Its valuation ratios aren't loaded yet, so there is no P/E to judge here.

DCF Fair Value (Educational)

A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.

How this DCF estimate is calculated

DCF fair value / share

—

Current price

$29.40

—

Starting FCF (latest 10-K)

$32.89M

Growth, years 1–5

4.0%

Fade to terminal, years 6–10

2.5%

Discount rate

9.0%

PV of 10-yr free cash flow$254.22M
PV of terminal value$310.52M
Estimated equity value$564.74M

Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.

Metrics vs. Sector Range

Where CHYM sits versus the Financials companies we cover.

TTM P/E
——
Forward P/E
——
P/S ratio
——
Revenue growth
——
EPS growth
——
Gross margin
88.0%Strong
Net margin
——
ROE
——

Bands show the middle half (25th–75th percentile) of the 141 Financials companies in our coverage that have fundamentals data — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.

Sector Peer Comparison

How CHYM stacks up against its Financials peers — valuation, profitability, and growth versus the sector median.

CHYM doesn't have a model rating yet (its fundamentals ratios aren't loaded), so it isn't ranked against the 141 rated Financials companies we cover.

P/E vs sector

—

median 14.9x

ROE vs sector

—

median 13.6%

Growth vs sector

—

median 15.9%

Sector rank

—

not rated yet

CompanyP/ERev Gr.Rating
CHYMThis stock——Not rated
JEF14.5x7.5%Weak· 38
SF12.8x9.0%Neutral· 48
EQH—-6.5%Weak· 0
PS51.9x—Neutral· 57
EVR17.7x47.3%Strong· 81
CRBG54.1x17.0%Weak· 37
FUTU10.4x53.0%Strong· 93
Financials median14.9x15.9%64/100

Valuation vs. quality map

sector medianJEFSFEVRCRBGFUTUP/E — cheaper ←→ pricierROE — more profitable ↑

The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.

Compare side by side

Peers are the closest Financials companies by sub-industry and size, preferring ones with full data. Sector medians and rank use the 141 rated companies among the 289 Financials stocks we cover. Educational, not a recommendation.

Key Risks

Research

Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.

Analyst Ratings

What 28 Wall Street analysts covering CHYM recommend (September 2026). Consensus is a useful sanity check — not a substitute for your own homework.

Buy
consensus · score 4.0 / 5 across 28 analysts
Strong Buy 5Buy 19Hold 4Sell 0Strong Sell 0

Latest SEC Filings

CHYM's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen. How to read a 10-K

CHYM — frequently asked questions

Is CHYM a good stock to buy?

We don't give buy or sell advice. Review Chime Financial Inc's fundamentals, valuation, and 5-year financials on this page, then make your own decision — and consider a licensed professional.

Where does CHYM's data come from?

Live price data plus the annual financials in Chime Financial Inc's SEC filings, refreshed automatically. Its fundamentals ratios aren't loaded yet, which is why it has no model rating.

How is the 5-year projection for CHYM calculated?

It's a scenario model. It starts from the latest annual revenue and net margin in SEC filings, grows revenue at an assumed rate (trailing revenue growth by default), and applies a P/E range built around today's multiple to show the resulting share-price range. When a stock has no growth or P/E data, the starting values are placeholders. It's a tool for thinking, not a prediction.

Is this CHYM analysis financial advice?

No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell CHYM. Always do your own research and consider a licensed professional.

Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.

Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.